Akebia Therapeutics Inc.
Search For a Symbol
|Market Cap (Intraday)||196.21M|
|2yr Forward PE||N/A|
Estimates Current Quarter
Akebia Therapeutics Inc. Stock, NASDAQ:AKBA
245 First Street, Suite 1400, Cambridge, Massachusetts 02142
United States of America
Number of Employees: 205
Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs for the treatment of renal and metabolic disorders. Its products include Auryxia and Vadadustat. The company was founded by Joseph H. Gardner, John M. Rice, Michael E. Pape, Josh P. Fairbank, and Robert A. Shalwitz on February 27, 2007 and is headquartered in Cambridge, MA.